Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Cooperative Signaling Through the STAT3 and NF-kB Pathways in Subtypes of DLBCL


ABSTRACT: The activated B cell-like (ABC) subgroup of diffuse large B cell lymphoma (DLBCL) is characterized by constitutive activation of the NF-êB pathway. Here we show that the NF- êB pathway induces the expression of the cytokines IL-6 and IL-10 in ABC DLBCL cell lines, which also have high levels of total and phosphorylated STAT3 protein, suggesting autocrine signaling. Using RNA interference for STAT3, we defined a gene expression signature of IL-6 and IL-10 signaling through STAT3. Based on this signature, we constructed a molecular predictor of STAT3 signaling that defined a subset of ABC DLBCL tumors with high expression of STAT3, IL-6 and/or IL-10, and their downstream targets. Although the STAT3-high and STAT3-low subsets had equivalent expression of genes that distinguish ABC DLBCL from GCB DLBCL, STAT3-high ABC DLBCLs had higher expression of signatures that reflected NF-kB activity, proliferation, and glycolysis. A smallmolecule inhibitor of JAK signaling, which blocked STAT3 signature expression, was toxic only for ABC DLBCL lines, and synergized with an inhibitor of NF-kB signaling. These findings suggest that the biological interplay between the STAT3 and NF-kB pathways may be exploited for the treatments of a subset of ABC DLBCLs. Activated B cell-like (ABC) subgroup of diffuse large B cell lymphoma (DLBCL) cell lines were used as model systems to study the cytokine pathways in these cells. We expressed inducible IkB super-repressor for 1 to 24 hours to identify NF-kB target genes in OCI-Ly3 and OCI-Ly10 cells for a total of 13 arrays with replicates of each time point. We treated OCI-Ly3 cells with IL-10 for 1 to 96 hours for a total of 10 arrays with replicates of each time point. We treated OCI-Ly10 cells with IL-6 for 30 minutes to 24 hours for a total of 8 arrays with replicates of each time point. OCI-Ly10 cells transfected with no siRNA versus STAT3-siRNA for 8, 24, or 48 hours for a total of 5 arrays with replicates for 24 and 48 hours. We treated OCI-Ly10 cells with JAK inhibitor I for 3 and 6 hours for a total of 4 arrays with replicates of each time point.

ORGANISM(S): Homo sapiens

SUBMITTER: Louis Staudt 

PROVIDER: E-GEOD-10009 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.

Lam Lloyd T LT   Wright George G   Davis R Eric RE   Lenz Georg G   Farinha Pedro P   Dang Lenny L   Chan John W JW   Rosenwald Andreas A   Gascoyne Randy D RD   Staudt Louis M LM  

Blood 20071226 7


The activated B cell-like (ABC) subgroup of diffuse large B-cell lymphoma (DLBCL) is characterized by constitutive activation of the nuclear factor-kappaB (NF-kappaB) pathway. In this study, we showed that the NF-kappaB pathway induced the expression of the cytokines interleukin (IL)-6 and IL-10 in ABC DLBCL cell lines, which also have high levels of total and phosphorylated signal transducer and activator of transcription (STAT) 3 protein, suggesting autocrine signaling. Using RNA interference  ...[more]

Similar Datasets

2009-06-01 | E-GEOD-11902 | biostudies-arrayexpress
2015-10-27 | E-GEOD-71526 | biostudies-arrayexpress
2010-05-26 | E-GEOD-7245 | biostudies-arrayexpress
2013-03-13 | E-GEOD-43878 | biostudies-arrayexpress
2013-12-16 | E-GEOD-50723 | biostudies-arrayexpress
2011-10-21 | E-GEOD-25192 | biostudies-arrayexpress
2007-12-21 | GSE10009 | GEO
2009-07-21 | E-GEOD-15416 | biostudies-arrayexpress
2009-04-01 | E-GEOD-11202 | biostudies-arrayexpress
2009-12-04 | E-GEOD-16936 | biostudies-arrayexpress